These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7033155)

  • 21. Radiolabeled iododeoxyuridine: safety evaluation.
    Harrison KA; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Lieberman RP; Sharp JG; Cohen SM; Leichner PK; Augustine SC; Tempero MA; Taylor RJ; Chiou RK
    J Nucl Med; 1996 Apr; 37(4 Suppl):13S-16S. PubMed ID: 8676196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of delayed chromosomal instability in a normal human fibroblast cell line after 125I iododeoxyuridine.
    Griffin CS; Neshasateh-Riz A; Mairs RJ; Wright EG; Wheldon TE
    Int J Radiat Biol; 2000 Jul; 76(7):963-9. PubMed ID: 10923620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotoxicity of 125I-iododeoxyuridine in pre-implantation mouse embryos.
    Narra VR; Howell RW; Thanki KH; Rao DV
    Int J Radiat Biol; 1991 Sep; 60(3):525-32. PubMed ID: 1679091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous and x-ray-induced genotypic and phenotypic resistance to 5-iodo-2'-deoxyuridine in lymphoma cells in vitro.
    Fox M
    Mutat Res; 1971 Dec; 13(4):403-19. PubMed ID: 5169173
    [No Abstract]   [Full Text] [Related]  

  • 26. Radiotoxicity of 125I-labeled monoclonal antibody 425 against cancer cells containing epidermal growth factor receptor.
    Derui L; Woo DV; Emrich J; Steplewski Z; Rodeck U; Herlyn D; Koprowski H; Miyamoto C; Brady LW
    Am J Clin Oncol; 1992 Aug; 15(4):288-94. PubMed ID: 1514524
    [No Abstract]   [Full Text] [Related]  

  • 27. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic applications of Auger and alpha emitting radionuclides.
    Bloomer WD; McLaughlin WH; Adelstein SJ; Wolf AP
    Strahlentherapie; 1984 Dec; 160(12):755-7. PubMed ID: 6393458
    [No Abstract]   [Full Text] [Related]  

  • 29. Anomalous effects of 125I after its incorporation into mammalian cell DNA.
    Painter RB; Young BR
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):472-9. PubMed ID: 565275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenic and lethal effects of [5-125I]iodo-2'-deoxyuridine incorporated into DNA of mammalian cells, and their RBEs.
    Miyazaki N; Fujiwara Y
    Radiat Res; 1981 Dec; 88(3):456-65. PubMed ID: 7313075
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytotoxicity of 125I decay in the DNA double strand break repair deficient mutant cell line, xrs-5.
    Yasui LS
    Int J Radiat Biol; 1992 Nov; 62(5):613-8. PubMed ID: 1361518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of 125I-oestrogen decay in non-oestrogen receptor-expressing human breast cancer cells, MDA-231 and oestrogen receptor-expressing MCF-7 cells.
    Yasui LS; Hughes A; Desombre ER
    Int J Radiat Biol; 2001 Sep; 77(9):955-62. PubMed ID: 11576455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell quality following irradiation: comparison of IUdR uptake in the spleen and number and size of splenic colonies in bone marrow transfused, fatally irradiated mice.
    Inoue T; Cronkite EP; Hübner GE; von Wangenheim KH; Feinendegen LE
    J Radiat Res; 1984 Dec; 25(4):261-73. PubMed ID: 6398365
    [No Abstract]   [Full Text] [Related]  

  • 34. N-ethylmaleimide and the cyclic response to x-rays of synchronous Chinese hamster cells.
    Sinclair WK
    Radiat Res; 1973 Jul; 55(1):41-57. PubMed ID: 4736799
    [No Abstract]   [Full Text] [Related]  

  • 35. 125IUDR labelling efficiency and cytotoxicity for murine tumours in vivo and in vitro.
    Hagmar B; Ryd W
    Eur J Nucl Med; 1982; 7(3):108-14. PubMed ID: 7067712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies with encapsulated 125I sources. II. Determination of the relative biological effectiveness using cultured mammalian cells.
    Freeman ML; Goldhagen P; Sierra E; Hall EJ
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1355-61. PubMed ID: 7141915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radio-iodine treatment of hyperthyroidism--a more liberal policy?
    Halnan KE
    Clin Endocrinol Metab; 1985 May; 14(2):467-89. PubMed ID: 4064351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioactively labeled iododeoxyuridine in the study of experimental liver regeneration.
    Bürki K; Schaer JC; Grétillat P; Schindler R
    Curr Top Pathol; 1975; 60():33-61. PubMed ID: 1104278
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiation biology and potential therapeutic applications of radionuclides.
    Hofer KG
    Bull Cancer; 1980; 67(3):343-53. PubMed ID: 7407434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vivo reproductive potential of density separated cells.
    Warters RL; Hofer KG
    Exp Cell Res; 1974 Jul; 87(1):143-51. PubMed ID: 4135369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.